v3.26.1
Segment Reporting
 3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Segment Information Segment Information
We have one operating and reportable segment, which is engaged in the development and commercialization of our Breast Acoustic CT Scanner. Our Chief Executive Officer has been determined to be the chief operating decision maker (“CODM”). The CODM assesses performance, makes operating decisions and decides how to allocate resources based on
net loss that is reported on the consolidated statements of operations and comprehensive loss. The measure of segment assets is reported on the consolidated balance sheets as total consolidated assets.
The following table presents information about reported segment revenue, significant segment expenses, and segment net loss for the three months ended March 31, 2026 and 2025 (in thousands):
Three Months Ended March 31,
20262025
Revenue
$6,530 $2,798 
Less:
    Cost of revenue (1)
3,858 986 
    Research and development (1)
1,724 852 
    Selling, general and administrative (1)
3,297 2,002 
    Other expense, net
4 8,749 
    Change in fair value of warrant liability
173 705 
    Change in fair value of derivative liability
— (101)
    Change in fair value of earnout liability
(50)50 
    Interest expense, net
930 691 
    Income tax benefit
— — 
 Consolidated net loss
$(3,406)$(11,136)
(1)    Includes total salaries, bonuses, employee benefits and stock-based compensation of $2.9 million and $1.6 million for the three months ended March 31, 2026 and 2025, respectively.
All of our long-lived assets are located in the United States.